Ascopiave Forecast, price target & analysts
Ascopiave Target price 2026 - Analyst rating & recommendation
Ascopiave Classifications & Recommendation
Ascopiave Price Target
| Target Price | €3.88 |
| Price | €2.65 |
| Potential |
46.26%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Ascopiave 2027 .
The average Ascopiave target price is €3.88.
This is
46.26%
register free of charge
€4.10
54.53%
register free of charge
€3.74
41.02%
register free of charge
|
|
| A rating was issued by 9 analysts: 0 Analysts recommend Ascopiave to buy, 5 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ascopiave stock has an average upside potential 2027 of
46.26%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 233.41 | 277.01 |
| 15.92% | 18.68% | |
| EBITDA Margin | 62.17% | 55.81% |
| 22.97% | 10.24% | |
| Net Margin | 37.21% | 14.73% |
| 109.16% | 60.41% |
4 Analysts have issued a sales forecast Ascopiave 2026 . The average Ascopiave sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Ascopiave EBITDA forecast 2026. The average Ascopiave EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Ascopiave Analysts have issued a net profit forecast 2026. The average Ascopiave net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.40 | 0.19 |
| 135.29% | 52.50% | |
| P/E | 14.06 | |
| EV/Sales | 4.42 |
4 Analysts have issued a Ascopiave forecast for earnings per share. The average Ascopiave EPS is
This results in the following potential growth metrics and future valuations:
Current Ascopiave Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| INTESA SANPAOLO EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Aug 31 2026 |
| EQUITA SIM |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| INTESA SANPAOLO EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 01 2026 |
| INTESA SANPAOLO EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jun 30 2026 |
| EQUITA SIM |
Locked
➜
Locked
|
Locked | May 08 2026 |
| EQUITA SIM |
Locked
➜
Locked
|
Locked | May 07 2026 |
| EQUITA SIM |
Locked
➜
Locked
|
Locked | Feb 13 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
INTESA SANPAOLO EQUITY RESEARCH:
Locked
➜
Locked
|
Aug 31 2026 |
|
Locked
EQUITA SIM:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
INTESA SANPAOLO EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 01 2026 |
|
Locked
INTESA SANPAOLO EQUITY RESEARCH:
Locked
➜
Locked
|
Jun 30 2026 |
|
Locked
EQUITA SIM:
Locked
➜
Locked
|
May 08 2026 |
|
Locked
EQUITA SIM:
Locked
➜
Locked
|
May 07 2026 |
|
Locked
EQUITA SIM:
Locked
➜
Locked
|
Feb 13 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
